Plain-English translation of NCT07024836 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is trying to understand what matters most to patients and doctors when deciding whether to take preventive treatment for latent TB infection (TB that is inactive but could become active in the future). Researchers will ask people being tested for TB, as well as healthcare workers, about their preferences and concerns regarding preventive treatment—to learn what factors influence whether people accept or decline this medication.
Many people with latent TB infection don't take preventive treatment, even though it can prevent serious illness. This study aims to understand the real-world barriers and preferences that affect these decisions, so doctors can better help patients make choices that are right for them.
You likely qualify if…
You likely don't qualify if…
If you join the first part of the study, you will take part in a one-on-one interview (20–30 people total) where researchers ask about your experiences with TB testing and thoughts about preventive treatment. If you join the second part, you will complete a survey where you are asked to make choices between different treatment options with different benefits and drawbacks (200 patients and 200 healthcare workers will do this). The study does not involve taking any medication—it is focused on understanding your preferences and decision-making.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
United Kingdom
Sponsor
University College, London
Collaborators
University of Aberdeen
Enrollment target
~430 participants
Started
May 2025
Primary completion
December 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in June 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Rishi K Gupta, PhD
University College, London
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.